» Articles » PMID: 35496387

HO-independent Chemodynamic Therapy Initiated from Magnetic Iron Carbide Nanoparticle-assisted Artemisinin Synergy

Overview
Journal RSC Adv
Specialty Chemistry
Date 2022 May 2
PMID 35496387
Authors
Affiliations
Soon will be listed here.
Abstract

Chemodynamic therapy (CDT) is a booming technology that utilizes Fenton reagents to kill tumor cells by transforming intracellular HO into reactive oxygen species (ROS), but insufficient endogenous HO makes it difficult to attain satisfactory antitumor results. In this article, a HO-free CDT technique with tumor-specificity is developed by using pH-sensitive magnetic iron carbide nanoparticles (PEG/FeC@FeO NPs) to trigger artemisinin (ART) to form ROS. ART-loaded PEG/FeC@FeO NPs are fabricated for the enormous release of Fe ions induced by the acidic conditions of the tumor microenvironment after magnetic-assisted tumor enrichment, which results in the rapid degradation of the PEG/FeC@FeO NPs and release of ART once endocytosed into tumor cells. catalysis reaction between the co-released Fe ions and ART generates toxic ROS and then induces apoptosis of tumor cells. Both and experiments demonstrate that the efficient Fe-enhanced and tumor-specific CDT efficacy for effective tumor inhibition based on ROS generation. This work provides a new direction to improve CDT efficacy based on HO-independent ROS generation.

Citing Articles

In Vitro Toxicological Insights from the Biomedical Applications of Iron Carbide Nanoparticles in Tumor Theranostics: A Systematic Review and Meta-Analysis.

Antoniou M, Melagraki G, Lynch I, Afantitis A Nanomaterials (Basel). 2024; 14(9).

PMID: 38727328 PMC: 11085367. DOI: 10.3390/nano14090734.

References
1.
Shahbazfar A, Zare P, Ranjbaran M, Tayefi-Nasrabadi H, Fakhri O, Farshi Y . A survey on anticancer effects of artemisinin, iron, miconazole, and butyric acid on 5637 (bladder cancer) and 4T1 (Breast cancer) cell lines. J Cancer Res Ther. 2015; 10(4):1057-62. DOI: 10.4103/0973-1482.137975. View

2.
Fu L, Qi C, Hu Y, Lin J, Huang P . Glucose Oxidase-Instructed Multimodal Synergistic Cancer Therapy. Adv Mater. 2019; 31(21):e1808325. DOI: 10.1002/adma.201808325. View

3.
Ding Y, Wan J, Zhang Z, Wang F, Guo J, Wang C . Localized Fe(II)-Induced Cytotoxic Reactive Oxygen Species Generating Nanosystem for Enhanced Anticancer Therapy. ACS Appl Mater Interfaces. 2018; 10(5):4439-4449. DOI: 10.1021/acsami.7b16999. View

4.
Yu J, Zhao F, Gao W, Yang X, Ju Y, Zhao L . Magnetic Reactive Oxygen Species Nanoreactor for Switchable Magnetic Resonance Imaging Guided Cancer Therapy Based on pH-Sensitive FeC@FeO Nanoparticles. ACS Nano. 2019; 13(9):10002-10014. DOI: 10.1021/acsnano.9b01740. View

5.
Yip N, Fombon I, Liu P, Brown S, Kannappan V, Armesilla A . Disulfiram modulated ROS-MAPK and NFκB pathways and targeted breast cancer cells with cancer stem cell-like properties. Br J Cancer. 2011; 104(10):1564-74. PMC: 3101904. DOI: 10.1038/bjc.2011.126. View